<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05118048</url>
  </required_header>
  <id_info>
    <org_study_id>NB19-SSLHH-NA-FDA</org_study_id>
    <nct_id>NCT05118048</nct_id>
  </id_info>
  <brief_title>StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood</brief_title>
  <official_title>CLIA Waived Study: StatStrip Lactate, Hemoglobin, and Hematocrit Meter in Whole Blood</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Nova Biomedical</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Buffalo General Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Erie County Medical Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Millard Fillmore Suburban Hospital</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Nova Biomedical</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>Yes</is_fda_regulated_device>
    <is_unapproved_device>Yes</is_unapproved_device>
    <is_us_export>Yes</is_us_export>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate the clinical utility of the StatStrip Lactate,&#xD;
      Hemoglobin and Hematocrit Hospital Meter System in the testing of whole blood specimens from&#xD;
      patients in hospital settings by CLIA waived operators, over a period of at least twenty&#xD;
      days. The specimens shall include capillary (obtained by fingerstick), and venous whole&#xD;
      blood. The study will also evaluate the use of a Fingerstick Blood Contamination Barrier for&#xD;
      capillary sampling from the fingertip. This submission to the FDA is intended for a Point of&#xD;
      Care (POC), CLIA waived device for whole blood capillary and venous lactate, and hemoglobin&#xD;
      and hematocrit measurements.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The study will be conducted at three (3) different healthcare settings (hereafter referred to&#xD;
      as &quot;testing sites&quot;) in POC sites/departments, by at least nine (9) CLIAW operators (at least&#xD;
      3 in each healthcare setting), over a period of at least twenty days at each healthcare&#xD;
      setting. Examples of hospital departments include (but are not limited to) Emergency&#xD;
      Department (ED), Intensive Care Unit (ICU), Pediatric Intensive Care Unit (PICU), Surgical&#xD;
      Intensive Care Unit (SICU), Medical Intensive Care Unit (MICU), Cardiac Intensive Care Unit&#xD;
      (CICU), Operating Room (OR), where point-of-care lactate, hemoglobin and hematocrit testing&#xD;
      can be utilized.&#xD;
&#xD;
      Each site will recruit at least 120 patients for a total of 360 adult patients in all three&#xD;
      (3) sites for each of the tests and specimen types. An attempt will be made to enroll 50%&#xD;
      males and 50% females.&#xD;
&#xD;
      Each Study Subject will provide:&#xD;
&#xD;
        1. Two (2) capillary whole blood fingerstick specimens&#xD;
&#xD;
             1. One Lactate capillary test using the Fingerstick Blood Contamination Barrier&#xD;
&#xD;
             2. One Hb/Hct capillary test following traditional fingerstick protocol&#xD;
&#xD;
        2. One (1) venous whole blood specimen obtained by venipuncture collected in a lithium&#xD;
           heparin tube or heparinized syringe:&#xD;
&#xD;
             1. One lactate venous test&#xD;
&#xD;
             2. One Hb/Hct venous test&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Patient recruitment too slowly&#xD;
  </why_stopped>
  <start_date type="Actual">January 18, 2021</start_date>
  <completion_date type="Actual">October 22, 2021</completion_date>
  <primary_completion_date type="Actual">October 22, 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Lactate comparison</measure>
    <time_frame>20 days</time_frame>
    <description>StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Lactate blood results in mmol/L</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Hemoglobin comparison</measure>
    <time_frame>20 days</time_frame>
    <description>StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Hemoglobin blood results in g/dL</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Analytical verification of StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System - Hematocrit comparison</measure>
    <time_frame>20 days</time_frame>
    <description>StatStrip Lactate, Hemoglobin and Hematocrit Hospital Meter System, a point of care testing instrument is as effective as a reference laboratory method for Hematocrit blood results in %</description>
  </primary_outcome>
  <enrollment type="Actual">285</enrollment>
  <condition>Sepsis</condition>
  <condition>Anemia</condition>
  <condition>Bleeding</condition>
  <condition>Erythrocytosis</condition>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Lactate, Hemoglobin, Hematocrit</intervention_name>
    <description>Compare diagnostic tests to reference methods</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Each site will recruit at least 120 patients for a total of 360 adult patients in all three&#xD;
        (3) sites for each of the tests and specimen types. An attempt will be made to enroll 50%&#xD;
        males and 50% females.&#xD;
&#xD;
        Each Study Subject will provide:&#xD;
&#xD;
          1. Two (2) capillary whole blood fingerstick specimens&#xD;
&#xD;
               1. One Lactate capillary test using the Fingerstick Blood Contamination Barrier&#xD;
&#xD;
               2. One Hb/Hct capillary test following traditional fingerstick protocol&#xD;
&#xD;
          2. One (1) venous whole blood specimen obtained by venipuncture collected in a lithium&#xD;
             heparin tube or heparinized syringe:&#xD;
&#xD;
               1. One lactate venous test&#xD;
&#xD;
               2. One Hb/Hct venous test&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Adult subjects (over or equal to 18 years old) with ordered hemoglobin and hematocrit&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Pediatric&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Brooke Lerner, PhD, FAEMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Buffalo General Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brooke Lerner, PhD, FAEMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Erie County Medical Center</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Brooke Lerner, PhD, FAEMS</last_name>
    <role>Principal Investigator</role>
    <affiliation>Millard Fillmore Suburban Hospital</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Buffalo General Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Erie County Medical Center</name>
      <address>
        <city>Buffalo</city>
        <state>New York</state>
        <zip>14203</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>Millard Fillmore Suburban Hospital</name>
      <address>
        <city>Williamsville</city>
        <state>New York</state>
        <zip>14221</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>July 2021</verification_date>
  <study_first_submitted>July 28, 2021</study_first_submitted>
  <study_first_submitted_qc>November 1, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 11, 2021</study_first_posted>
  <last_update_submitted>November 1, 2021</last_update_submitted>
  <last_update_submitted_qc>November 1, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 11, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lactate</keyword>
  <keyword>Hemoglobin</keyword>
  <keyword>Hematocrict</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Polycythemia</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

